As the number one "killer" of the elderly, cardiovascular and cerebrovascular diseases are increasingly becoming one of the main health threats to Chinese people. As one of the high incidence cardiovascular and cerebrovascular diseases, atrial fibrillation is still unfamiliar to many people. At present, the number of patients with atrial fibrillation in China is as high as 10 million. The long-term irregular beating of the heart of patients with atrial fibrillation will not only lead to heart enlargement and heart failure, but also easily cause blood flow to accumulate in the left atrial appendage and repeatedly form thrombosis. There is a risk of stroke, and the mortality is as high as 20%. It is understood that one in six stroke patients is due to atrial fibrillation. So how to identify atrial fibrillation, what are the contraindications to taking medicine after diagnosis, or can surgery solve the problem once and for all? On November 25, Ye Ping, Department of cardiovascular medicine of Wuhan Central Hospital, will be invited to the live broadcast room of Changjiang Daily to answer questions and solve doubts. He will also share his experience in jointly managing diseases with patients. "Atrial fibrillation, fully known as atrial fibrillation. If the heart is compared to a house, the wall of the heart is full of circuits in the house, atrial fibrillation is the most common phenomenon of atrial circuit disorder." Ye Ping introduced that although simple radiofrequency ablation can calm most of the beating hearts, it still can not guarantee that patients will not have thromboembolism for many high-risk groups. At present, the hospital can implement one-stop minimally invasive combined surgery, one "elimination" and one "blockage", which is a good double insurance to prevent sudden death of stroke in patients with atrial fibrillation. It is reported that most patients with atrial fibrillation mainly rely on drug treatment to alleviate their condition. After the one-stop minimally invasive treatment is widely used, millions of patients will be able to bid farewell to the trouble of lifelong medication. (outlook new era)